Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 21;31(14):S6-S16.
doi: 10.12968/bjon.2022.31.14.S6.

Alteplase for the treatment of midline catheter occlusions: a retrospective, single-cohort descriptive study

Affiliations

Alteplase for the treatment of midline catheter occlusions: a retrospective, single-cohort descriptive study

Elsie Rizk et al. Br J Nurs. .

Abstract

Background: Despite the increasing popularity of midline catheters, data on the use of alteplase for restoring midline catheter patency is scarce.

Aims: This study aimed to evaluate off-label use of alteplase for midline catheter occlusions.

Method: Adults who received alteplase into a midline catheter between January 2015 and May 2018 within a multi-hospital health system were included in this study. The primary outcome was restoration of infusion or withdrawal function from at least one lumen of a treated midline catheter.

Findings: Following alteplase administration, withdrawal function was restored in 47% (25/53) of occlusion events, infusion function was restored in 65% (11/17) of complete occlusion events, and infusion or withdrawal function was restored in 58% (31/53) of occlusion events. Only 34% (17/50) of catheters were replaced because of malfunction. Local bleeding was documented in 9% (n=5) of occlusion events after alteplase administration.

Conclusion: Most midline catheter occlusions treated with alteplase demonstrated restoration of infusion or withdrawal function.

Keywords: Alteplase; Complete catheter occlusion; Midline catheter; Occlusion; Partial catheter occlusion.

PubMed Disclaimer

Substances

LinkOut - more resources